Formed roughly ten years ago with IP rooted in the University of Minnesota, MMS focuses on technology applied to medication adherance and pharmacotherapy. The company’s website speaks to a forthcoming software system, perhaps what the capital is going for:
“Our new tool set drives clinical documentation, data analytics, reporting, and billing. It enables efficient identification of drug therapy problems and analysis of treatment data; creation of medication action plans; and documentation of patient and prescriber communications. Our robust application links the most critical data necessary for sound decision making to achieve better health outcomes.”
Other locals into pharmatech include newcomer Dose Health with their software + hardware box, and OneOme, which is pursuing pharmacogenomics in partnership with the Mayo Clinic. Anser Innovation has also hinted at expanding their ‘Pet Chatz’ product into the space as well.